Trial Profile
A Study to Evaluate the Safety and Efficacy of Lamivudine/abacavir in Patients with HIV Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Lamivudine/abacavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record